Clovis Oncology, Inc. Accounts Receivable
Clovis Oncology, Inc. had Accounts Receivable of $19.45 million as of 2022-09-30, per its 10-Q filed 2022-11-09.
Discontinued › Balance Sheet › Assets › Assets, Current › Receivables, Net, Current
us-gaap:AccountsReceivableNetCurrent · last filed 2022-11-09
- 2022-09-30: Accounts Receivable, after Allowance for Credit Loss, Current $19.45M.
- 2022-06-30: Accounts Receivable, after Allowance for Credit Loss, Current $18.57M.
- 2022-03-31: Accounts Receivable, after Allowance for Credit Loss, Current $27.30M.
- 2021-12-31: Accounts Receivable, after Allowance for Credit Loss, Current $26.87M.
| Period end | Accounts Receivable, after Allowance for Credit Loss, Current |
|---|---|
| 2022-09-30 | $19.45M 10-Q · filed 2022-11-09 |
| 2022-06-30 | $18.57M 10-Q · filed 2022-08-08 |
| 2022-03-31 | $27.30M 10-Q · filed 2022-05-05 |
| 2021-12-31 | $26.87M 10-Q · filed 2022-11-09 |
| 2021-09-30 | $25.78M 10-Q · filed 2021-11-03 |
| 2021-06-30 | $24.18M 10-Q · filed 2021-08-04 |
| 2021-03-31 | $21.73M 10-Q · filed 2021-05-05 |
| 2020-12-31 | $26.51M 10-K · filed 2022-02-24 |
| 2020-09-30 | $20.27M 10-Q · filed 2020-11-05 |
| 2020-06-30 | $18.20M 10-Q · filed 2020-08-07 |
| 2020-03-31 | $25.08M 10-Q · filed 2020-05-06 |
| 2019-12-31 | $20.56M 10-K · filed 2021-02-25 |
| 2019-09-30 | $16.82M 10-Q · filed 2019-11-07 |
| 2019-06-30 | $15.38M 10-Q · filed 2019-08-02 |
| 2019-03-31 | $16.10M 10-Q · filed 2019-05-07 |
| 2018-12-31 | $12.89M 10-K · filed 2020-02-26 |
| 2018-09-30 | $14.49M 10-Q · filed 2018-11-01 |
| 2018-06-30 | $12.30M 10-Q · filed 2018-08-02 |
| 2018-03-31 | $12.94M 10-Q · filed 2018-05-09 |
| 2018-01-01 | $9.52M 10-K · filed 2019-02-28 |
| 2017-12-31 | $6.18M 10-K · filed 2019-02-28 |
| 2017-06-30 | $1.14M 10-Q · filed 2017-08-03 |
| 2017-03-31 | $2.38M 10-Q · filed 2017-05-04 |
| 2016-12-31 | $121.00K 10-K · filed 2018-02-27 |
| 2015-12-31 | $0.00 10-K · filed 2017-02-23 |